日光角化症市場：治療タイプ別、エンドユーザー別、地域別

世界の日光角化症市場は、2025年には91億8,000万米ドルと推定され、2032年には130億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR5.1％で成長すると予測されています。

図.日光角化症市場シェア（%）、2025年地域別

日光角化症は、太陽からの紫外線に長期間さらされることによって引き起こされる前がん性皮膚疾患です。顔、唇、耳、禿げた頭皮、前腕、手の甲、下唇など、日光にさらされた部分にできる鱗屑や痂皮のような斑点が特徴です。これらの斑点は、表皮の上層にあるケラチノサイトの異常で制御不能な増殖によって引き起こされます。放置すると、皮膚がんの一種である扁平上皮がんに発展する可能性があります。皮膚の健康と早期診断に関する意識の高まりが、世界の日光角化症市場の成長を牽引しています。

市場力学：

世界の日光角化症市場は、主に日焼けによる有病率の増加が牽引しています。長時間の無防備な紫外線暴露は、日光角化症の主な危険因子です。屋外でのレクリエーション活動や職業的な日光曝露の増加に伴い、効果的な治療および管理オプションに対する需要は着実に増加しています。さらに、治療法に対する有利な償還政策や、新しい治療法の承認が増加していることも、市場成長に拍車をかけています。しかし、ブランド薬の高価格は依然として重要な課題です。より優れた効能と治療期間の短縮を実現する新しい製剤に関する継続的な研究は、この課題を克服し、世界の日光角化症市場にさらなる成長機会をもたらす可能性があります。

本調査の主な特徴

• 本レポートでは、世界の日光角化症市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 世界の日光角化症市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• 主要企業には、Almirall, S.A.、Bausch Health Companies Inc.、Perrigo Company plc.、Sun Pharmaceutical Industries Ltd.、Hill Dermaceuticals, Inc.、Tolmar Pharmaceuticals, Inc.、Bioforntera AG、Cipher Pharmaceuticals Inc.、Vidac、Athenex, Inc.、GALDERMA、LEO Pharma A/Sなどがあります。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の日光角化症市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の日光角化症市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 製品の発売/承認
• ブランドと価格分析
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の日光角化症市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の日光角化症市場、治療タイプ別、2020年-2032年（10億米ドル）

• 局所治療
• 手術手技
• 光線力学療法
• その他

第6章 世界の日光角化症市場、エンドユーザー別、2020年-2032年、（10億米ドル）

• 病院
• 皮膚科クリニック
• スパと若返りセンター
• ホームケア設定
• その他

第7章 世界の日光角化症市場、地域別、2020年-2032年（10億米ドル）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• 企業プロファイル
  • Almirall, SA
  • Bausch Health Companies Inc.
  • Perrigo Company plc.
  • Sun Pharmaceutical Industries Ltd.
  • Hill Dermaceuticals, Inc.
  • Tolmar Pharmaceuticals, Inc.
  • Bioforntera AG
  • Cipher Pharmaceuticals Inc.
  • Vidac
  • Athenex, Inc.
  • GALDERMA
  • LEO Pharma A/S

第9章 アナリストの視点

• 機会
• アナリストの見解
• Coherent Opportunity Map

第10章 参考文献と調査手法

• 参考文献
• 調査手法

Global Actinic Keratosis Market is estimated to be valued at USD 9.18 Bn in 2025 and is expected to reach USD 13.01 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Figure. Actinic Keratosis Market Share (%), By Region 2025

Actinic keratosis is a precancerous skin condition caused by prolonged exposure to UV radiation from the sun. It is characterized by scaly or crusty patches that develop on sun-exposed areas like the face, lips, ears, bald scalp, forearms, the back of the hands, and lower lips. These patches are caused by the abnormal and uncontrolled growth of keratinocytes in the upper layer of the epidermis. If left untreated, actinic keratosis has the potential to develop into squamous cell carcinoma, a type of skin cancer. Rising awareness regarding skin health and early diagnosis has been driving the global actinic keratosis market growth.

Market Dynamics:

The global actinic keratosis market is primarily driven by the increasing prevalence of the condition owing to sun exposure. Prolonged and unprotected exposure to ultraviolet radiation is the main risk factor for actinic keratosis. With rising outdoor recreational activities and occupational sun exposure, the demand for effective treatment and management options is steadily increasing. Additionally, favorable reimbursement policies for treatment procedures and increasing approval of new treatment modalities are providing impetus to the market growth. However, high cost of branded drugs remains a key challenge. Ongoing research into new formulations with better efficacy and reduced treatment duration can help overcome this challenge and further create growth opportunities in the global actinic keratosis market.

Key Features of the Study:

• This report provides an in-depth analysis of the global actinic keratosis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global actinic keratosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Almirall, S.A, Bausch Health Companies Inc., Perrigo Company plc., Sun Pharmaceutical Industries Ltd., Hill Dermaceuticals, Inc., Tolmar Pharmaceuticals, Inc., Bioforntera AG, Cipher Pharmaceuticals Inc., Vidac, Athenex, Inc., GALDERMA, and LEO Pharma A/S.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global actinic keratosis market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global actinic keratosis market.

Detailed Segmentation-

• By Treatment Type:
  • Topical Treatment
  • Surgical Procedure
  • Chemical peels
  • Cryosurgery
  • Curettage and desiccation
  • Others
  • Photodynamic Therapy
  • Others
• By End User:
  • Hospitals
  • Dermatology Clinics
  • Spas and Rejuvenation Centers
  • Homecare Settings
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Perrigo Company plc.
  • Sun Pharmaceutical Industries Ltd.
  • Hill Dermaceuticals, Inc.
  • Tolmar Pharmaceuticals, Inc.
  • Bioforntera AG
  • Cipher Pharmaceuticals Inc.
  • Vidac
  • Athenex, Inc.
  • GALDERMA
  • LEO Pharma A/S

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Brand and Pricing Analysis
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Actinic Keratosis Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Actinic Keratosis Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Topical Treatment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Surgical Procedure
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemical peels
  • Cryosurgery
  • Curettage and desiccation
  • Others
• Photodynamic Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Actinic Keratosis Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatology Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spas and Rejuvenation Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Actinic Keratosis Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
  • Almirall, S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Perrigo Company plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Hill Dermaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Tolmar Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bioforntera AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Cipher Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Vidac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Athenex, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GALDERMA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • LEO Pharma A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"